<DOC>
	<DOCNO>NCT01208298</DOCNO>
	<brief_summary>The primary objective study evaluate safety performance cold sore patch treatment herpes labialis .</brief_summary>
	<brief_title>Study Evaluate Using Cold Sore Patch Treat Herpes Labialis</brief_title>
	<detailed_description>This open , single-center multi-site , non-comparative study evaluate safety performance CSP-Night actual-use condition subject herpes labialis lip and/or perioral skin . A sufficient number subject screen ensure 45 subject experience treated cold sore outbreak course 14 week . Subjects instructed initiate therapy within approximately 1 hour onset first sign symptom . Treatment continue lesion heal , maximum 10 day . All subject expect return study center clinical assessment within 24 hour 48 hour initiate treatment , every day thereafter , final visit Day 10 time completion/discontinuation Day 10 . Diaries complete day , begin upon initiation therapy continue study completion/ discontinuation , include information study product application compliance .</detailed_description>
	<mesh_term>Herpes Labialis</mesh_term>
	<criteria>Females male subject , least 18 70 year age , good general health History recurrent herpes labialis ( HSV1 ) lips and/or perioral skin , lesion typically manifest classical lesion ( i.e. , episodes progress vesicle , ulcer , and/or crust stage ) . Based history , subject consider likely experience cold sore outbreak within time period 23 month Individuals willing able provide inform consent Willing stop treatment condition test period , include cream , tablet treatment Agrees use topical product ( e.g. , cosmetic , lip balm , sunscreen ) lesion area study medication Individuals willing use assign test material 10 consecutive day Individuals willing able follow requirement study participation Women child bear potential must agree use adequate method birth control define protocol . Females postmenopausal ( least 1 year ) , hysterectomy , bilateral ovariectomy bilateral tubal ligation additional birth control method . Individuals self report pregnant , plan become pregnant nursing History viral infection ( e.g. , hepatitis , HIV ) condition likely require treatment systemic antiviral steroid medication period study Note : Subjects suffer chronic HSV and/ previously treat herpes virus systemic medication permit enrolled study . History malignant disease Significant history liver , kidney , heart , lung digestive disease require prolonged hospitalization outpatient treatment Significant history blood , nerve , brain psychiatric disorder require prolonged hospitalization outpatient treatment Individuals uncontrolled diabetes History dermatologic condition ( ) judgment investigator may affect course cold sore lesion interfere action study treatment confound interpretation study result Individuals use analgesic antiinflammatory agent treatment period Individuals take take within past 30 day commence treatment , systemic antiviral steroid therapy Individuals take take within past 7 day commence treatment , topical treatment cold sore Individuals take herbal supplement within 28 day first dose study product Employees investigator study center , direct involvement propose study study direction investigator study center , well family member employee investigator Individuals know sensitivity ingredient test product Individuals participate another clinical research study , within 30 day Visit 1 time course treatment period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Cold Sore Patch</keyword>
</DOC>